Treatment options for the management of acute leukaemia relapsing following an allogeneic transplant.
The management of acute leukaemia which relapses following an allogeneic stem cell transplant remains a major challenge. In this review we summarize the outcomes of the currently available treatment modalities and discuss emerging novel approaches.
Shaw
B E
BE
Section of Haemato-Oncology, Royal Marsden Hospital, Surrey, UK. bshaw@doctors.org.uk
Russell
N H
NH
D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects*; D006801:Humans; D016219:Immunotherapy, Adoptive; D015470:Leukemia, Myeloid, Acute / Q000628:therapy*; D018365:Neoplasm, Residual; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000628:therapy*; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use; D012008:Recurrence; D014184:Transplantation, Homologous
D047428:Protein Kinase Inhibitors